Brain Stimulation Reduces Spasticity after Spinal Cord Injury
|
By HospiMedica International staff writers Posted on 03 Jul 2017 |
|
A new study claims that excitatory intermittent theta burst stimulation (iTBS) is successful in reducing spasticity in patients with spinal cord injury (SCI).
Researchers at Paracelsus Medical University (Salzburg, Austria), the University of Verona (Italy), and other institutions conducted a study to investigate if iTBS, a safe, non-invasive and well-tolerated protocol of excitatory repetitive transcranial magnetic stimulation (rTMS), is effective in modulating spasticity. The study included ten subjects with incomplete cervical or thoracic SCI. Five patients received 10 days of real or iTBS, and the remaining five received sham treatment. After two months, the sham group was switched to real iTBS and the study continued.
The researchers measured motor-evoked potentials (MEP) in the soleus (calf muscle), during magnetic stimulation over the most responsive area of the scalp. M-wave and H reflexes, which are measures of muscle contractions due to stimulation of the tibial nerve, were assessed for each subject, and an H/M amplitude ratio was determined. Modified Ashworth Scale (MAS) and the Spinal Cord Injury Assessment Tool for Spasticity (SCAT) were also compared before and after the stimulation protocols.
The results showed that patients receiving real iTBS showed significant increased resting and active MEPs amplitude and a significant reduction of the H/M amplitude ratio. In addition, both MAS and SCAT scores were significantly reduced after treatment. The changes persisted up to one week after the end of the iTBS treatment, and were not observed under the sham-iTBS condition, suggesting that iTBS may be a promising therapeutic tool for spasticity in SCI patients. The study was published on June 6, 2017, in Restorative Neurology and Neuroscience.
“Patients receiving real iTBS, compared to those receiving sham treatment, showed significant improvement,” said lead author Raffaele Nardone, MD, PhD, of Paracelsus Medical University. “In comparison with standard rTMS protocols, iTBS represents a more feasible approach because of lower stimulation intensity and shorter duration of application in each single session.”
Spasticity is a muscle control disorder caused by an imbalance between signals from the central nervous system (CNS) to the muscles. It is often found in people with cerebral palsy, traumatic brain injury (TBI), SCI, stroke, and multiple sclerosis (MS). It is characterized by increased muscle tone, overactive reflexes, involuntary movements, which may include spasms and clonus, pain, decreased functional abilities, abnormal posture, contractures, and bone and joint deformities.
Related Links:
Paracelsus Medical University
University of Verona
Researchers at Paracelsus Medical University (Salzburg, Austria), the University of Verona (Italy), and other institutions conducted a study to investigate if iTBS, a safe, non-invasive and well-tolerated protocol of excitatory repetitive transcranial magnetic stimulation (rTMS), is effective in modulating spasticity. The study included ten subjects with incomplete cervical or thoracic SCI. Five patients received 10 days of real or iTBS, and the remaining five received sham treatment. After two months, the sham group was switched to real iTBS and the study continued.
The researchers measured motor-evoked potentials (MEP) in the soleus (calf muscle), during magnetic stimulation over the most responsive area of the scalp. M-wave and H reflexes, which are measures of muscle contractions due to stimulation of the tibial nerve, were assessed for each subject, and an H/M amplitude ratio was determined. Modified Ashworth Scale (MAS) and the Spinal Cord Injury Assessment Tool for Spasticity (SCAT) were also compared before and after the stimulation protocols.
The results showed that patients receiving real iTBS showed significant increased resting and active MEPs amplitude and a significant reduction of the H/M amplitude ratio. In addition, both MAS and SCAT scores were significantly reduced after treatment. The changes persisted up to one week after the end of the iTBS treatment, and were not observed under the sham-iTBS condition, suggesting that iTBS may be a promising therapeutic tool for spasticity in SCI patients. The study was published on June 6, 2017, in Restorative Neurology and Neuroscience.
“Patients receiving real iTBS, compared to those receiving sham treatment, showed significant improvement,” said lead author Raffaele Nardone, MD, PhD, of Paracelsus Medical University. “In comparison with standard rTMS protocols, iTBS represents a more feasible approach because of lower stimulation intensity and shorter duration of application in each single session.”
Spasticity is a muscle control disorder caused by an imbalance between signals from the central nervous system (CNS) to the muscles. It is often found in people with cerebral palsy, traumatic brain injury (TBI), SCI, stroke, and multiple sclerosis (MS). It is characterized by increased muscle tone, overactive reflexes, involuntary movements, which may include spasms and clonus, pain, decreased functional abilities, abnormal posture, contractures, and bone and joint deformities.
Related Links:
Paracelsus Medical University
University of Verona
Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Patient Warming Blanket
Patient Warming Blanket
New
Vacuum-Assisted Breast Biopsy Device
Celero
Latest Surgical Techniques News
- Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
- Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
- World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
- AI-Generated Synthetic Scarred Hearts Aid Atrial Fibrillation Treatment
- New Class of Bioadhesives to Connect Human Tissues to Long-Term Medical Implants
- New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation
- Minimally Invasive Valve Repair Reduces Hospitalizations in Severe Tricuspid Regurgitation Patients
- Tiny Robotic Tools Powered by Magnetic Fields to Enable Minimally Invasive Brain Surgery
- Magnetic Tweezers Make Robotic Surgery Safer and More Precise
- AI-Powered Surgical Planning Tool Improves Pre-Op Planning
- Novel Sensing System Restores Missing Sense of Touch in Minimally Invasive Surgery
- Headset-Based AR Navigation System Improves EVD Placement
- Higher Electrode Density Improves Epilepsy Surgery by Pinpointing Where Seizures Begin
- Open-Source Tool Optimizes Placement of Visual Brain Implants
- Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
- Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Channels
Critical Care
view channel
Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market
Intestinal gases are associated with several health conditions, including colon cancer, irritable bowel syndrome, and inflammatory bowel disease, and they have the potential to serve as crucial biomarkers... Read more
Novel Cannula Delivery System Enables Targeted Delivery of Imaging Agents and Drugs
Multiphoton microscopy has become an invaluable tool in neuroscience, allowing researchers to observe brain activity in real time with high-resolution imaging. A crucial aspect of many multiphoton microscopy... Read more
Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
Until now, administering cell therapies to patients on extracorporeal membrane oxygenation (ECMO)—a life-support system typically used for severe lung failure—has been nearly impossible.... Read more
Patient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read more
Business
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more
